Biothera Pharmaceuticals Announces Management Changes

EAGAN, MN — December 13, 2018 — Biothera Pharmaceuticals, Inc. announced today that Chief Executive Officer Barry Labinger has resigned to pursue another opportunity, effectively immediately.  Biothera Holding Corp. Chairman Richard Mueller has been appointed acting CEO.  Jeremy Graff, Ph.D., has been named President in addition to his position as Chief Scientific Officer.  Dr. Graff will have responsibility for Research, Clinical Operations and Manufacturing.  Since...

Read More